[CHRS] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
05-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 217.81%
YoY- 154.01%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 116,180 123,856 111,684 83,433 37,098 0 0 -
PBT 36,505 41,271 47,890 23,618 -20,004 -62,596 -58,826 -
Tax 933 2,044 847 51 5,027 70 2,978 -53.83%
NP 35,572 39,227 47,043 23,567 -20,004 -62,596 -58,808 -
Tax Rate -2.56% -4.95% -1.77% -0.22% - - - -
Total Cost 80,608 84,629 64,641 59,866 57,102 62,596 58,808 23.37%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin 30.62 31.67 42.12 28.25 -53.92 0.00 0.00 -
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS 0.50 0.56 0.67 0.34 -0.29 -0.92 -0.87 -
EPS Diluted 0.48 0.53 0.63 0.32 -0.29 -0.92 -0.87 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.